Lungs from BLM–treated mice displayed upregulated levels of α-SMA and increased numbers of α-SMA-positive cells, and these effects were significantly suppressed by HSM pretreatment (Fig. 3e). This evidence concerns the gene ACTA1 and Bloom syndrome.